Paul Mahon
Fortuna: 24 M $ al 30/06/2026
Fortuna: 24 M $ al 30/06/2026
Paul A. Mahon is Co-Managing Director at Unither Therapeutik GmbH.
Mr. Mahon is Secretary, Executive VP & General Counsel at United Therapeutics Corp.
since 2003.
Mr. Mahon is Secretary, Executive VP & General Counsel at Miromatrix Medical, Inc. since 2023.
Mr. Mahon is partner at Hyperion Equity Partners Ltd. Mr. Mahon was Director at SteadyMed Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/07/2026 | 45.172 ( 0,11 % ) | 24 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Consejero General | 26/06/1996 |
| MIROMATRIX MEDICAL INC. | Consejero General | 11/12/2023 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| STEADYMED LTD | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miromatrix Medical, Inc.
Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.